Advanced search
Publication Cover
Future Virology Volume 8, 2013 - Issue 6
Submit an article Journal homepage
85
Views
0
CrossRef citations to date
0
Altmetric
Review

Vitamin D and HIV Infection: A Review of the Clinical Evidence

Ali Tafazoli1 Department of Clinical Pharmacy, Faculty of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran
&
Hossein Khalili2 Department of Clinical Pharmacy, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, 1417614411, PO Box 14155/6451, Iran.Correspondence[email protected]
Pages 589-606 | Published online: 31 May 2013

References

  • Beard JA , BeardenA, StrikerR. Vitamin D and the anti-viral state. J. Clin. Virol.50(3) , 194–200 (2011).
  • Babameto G , KotlerDP. Malnutrition in HIV infection. Gastroenterol. Clin. North. Am.26(2) , 393–415 (1997).
  • Shahar E , SegalE, RozenGSet al. Vitamin D status in young HIV infected women of various ethnic origins: incidence of vitamin D deficiency and possible impact on bone density. Clin. Nutr. 2 , 456–462 (2012).
  • Adeyemi OM , AgnielD, FrenchALet al. Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J. Acquir. Immune Defic. Syndr. 57(3) , 197–204 (2011).
  • Mehta S , HunterDJ, MugusiFMet al. Perinatal outcomes, including mother-to-child transmission of HIV, and child mortality and their association with maternal Vitamin D status in Tanzania. J. Infect. Dis. 200(7) , 1022–1030 (2009).
  • Conrado T , Miranda-Filho Dde B, Ximenes RA et al. Vitamin D deficiency in HIV-infected women on antiretroviral therapy living in the tropics. J. Int. Assoc. Physicians AIDS Care (Chic.)10(4) , 239–245 (2011).
  • Stein EM , YinMT, McMahonDJet al. Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African–American women. Osteoporos. Int. 22(2) , 477–487 (2011).
  • Cervero M , AgudJ, García-LacalleCet al. Prevalence of vitamin D deficiency and its related risk factor in a Spanish cohort of adult HIV-infected patients: effects of antiretroviral therapy. AIDS Res. Hum. Retrovi. 28(9) , 963–971 (2012).
  • Allavena C , DelpierreC, CuzinLet al. High frequency of vitamin D deficiency in HIV-infected patients: effects of HIV-related factors and antiretroviral drugs. J. Antimicrob. Chemother. 67(9) , 2222–2230 (2012).
  • Nansera D , GrazianoFM, FriedmanDJ, BobbsMK, JonesAN, HansenKE. Vitamin D and calcium levels in Ugandan adults with human immunodeficiency virus and tuberculosis. Int. J. Tuberc. Lung Dis.15(11) , 1522–1527 (2011).
  • Vescini F , Cozzi-LepriA, BorderiMet al.; Icona Foundation Study Group. Prevalence of hypovitaminosis D and factors associated with vitamin D deficiency and morbidity among HIV-infected patients enrolled in a large Italian cohort. J. Acquir. Immune Defic. Syndr.58(2) , 163–172 (2011).
  • Dao CN , PatelP, OvertonETet al.; Study to Understand the Natural History of HIV and AIDS in the Era of Effective Therapy (SUN) Investigators. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population. Clin. Infect. Dis.52(3) , 396–405 (2011).
  • Stephensen CB , MarquisGS, KruzichLA, DouglasSD, AldrovandiGM, WilsonCM. Vitamin D status in adolescents and young adults with HIV infection. Am. J. Clin. Nutr.83(5) , 1135–1141 (2006).
  • Haug CJ , AukrustP, HaugE, M⊘rkridL, MüllerF, Fr⊘landSS. Severe deficiency of 1,25-dihydroxyvitamin D3 in human immunodeficiency virus infection: association with immunological hyperactivity and only minor changes in calcium homeostasis. J. Clin. Endocrinol. Metab.83(11) , 3832–3838 (1998).
  • Conesa-Botella A , FlorenceE, LynenL, ColebundersR, MentenJ, Moreno-ReyesR. Decrease of vitamin D concentration in patients with HIV infection on a non-nucleoside reverse transcriptase inhibitor-containing regimen. AIDS Res. Ther.7 , 40 (2010).
  • Etminani-Esfahani M , KhaliliH, SoleimaniNet al. Serum vitamin D concentration and potential risk factors for its deficiency in HIV positive individuals. Curr. HIV Res. 10(2) , 165–170 (2012).
  • Haug C , MüllerF, AukrustP, Fr⊘landSS. Subnormal serum concentration of 1,25-vitamin D in human immunodeficiency virus infection: correlation with degree of immune deficiency and survival. J. Infect. Dis.169(4) , 889–893 (1994).
  • Terrier B , CarratF, GeriGet al. Low 25-OH vitamin D serum levels correlate with severe fibrosis in HIV–HCV co-infected patients with chronic hepatitis. J. Hepatol. 55(4) , 756–761 (2011).
  • Ormesher B , DhaliwalS, NylenEet al. Vitamin D deficiency is less common among HIV-infected African–American men than in a matched cohort. AIDS 25(9) , 1237–1239 (2011).
  • Mueller NJ , FuxCA, LedergerberBet al.; Swiss HIV Cohort Study. High prevalence of severe vitamin D deficiency in combined antiretroviral therapy-naive and successfully treated Swiss HIV patients. AIDS24(8) , 1127–1134 (2010).
  • Van Den Bout-Van Den Beukel CJ , FievezL, MichelsMet al. Vitamin D deficiency among HIV type 1-infected individuals in The Netherlands: effects of antiretroviral therapy. AIDS Res. Hum. Retroviruses 24(11) , 1375–1382 (2008).
  • Oyedele T , AdeyemiOM. High prevalence of vitamin D deficiency in HIV-infected adults: What are the future research questions? Curr. HIV/AIDS Rep.9(1) , 1–4 (2012).
  • Wasserman P , RubinDS. Highly prevalent vitamin D deficiency and insufficiency in an urban cohort of HIV-infected men under care. AIDS Patient Care STDS24(4) , 223–227 (2010).
  • Conrado T , Miranda-Filho Dde B, Bandeira F. [Vitamin D deficiency in HIV-infected individuals: one more risk factor for bone loss and cardiovascular disease?] Arq. Bras. Endocrinol. Metabol.54(2) , 118–122 (2010).
  • Rodríguez M , DanielsB, GunawardeneS, RobbinsGK. High frequency of vitamin D deficiency in ambulatory HIV-positive patients. AIDS Res. Hum. Retroviruses25(1) , 9–14 (2009).
  • Viard JP , SouberbielleJC, KirkOet al.; EuroSIDA Study Group. Vitamin D and clinical disease progression in HIV infection: results from the EuroSIDA study. AIDS25(10) , 1305–1315 (2011).
  • Frontini M , NnadiJ, BairuS, KhanT, ChotaliaJ, ClarkRA. Risk factors for suboptimal vitamin D levels among adults with HIV attending an inner-city clinic of New Orleans, Louisiana. J. La State Med. Soc.164(1) , 10–12 (2012).
  • Mehta S , GiovannucciE, MugusiFMet al. Vitamin D status of HIV-infected women and its association with HIV disease progression, anemia, and mortality. PLoS ONE 5(1) , e8770 (2010).
  • Crutchley RD , GatheJ Jr, Mayberry C, Trieu A, Abughosh S, Garey KW. Risk factors for vitamin D deficiency in HIV-infected patients in the south central United States. AIDS Res. Hum. Retroviruses28(5) , 454–459 (2012).
  • Kim JH , GandhiV, PsevdosG Jr, Espinoza F, Park J, Sharp V. Evaluation of vitamin D levels among HIV-infected patients in New York City. AIDS Res. Hum. Retroviruses28(3) , 235–241 (2012).
  • Torres C , Sánchez de la Torre M, García-Moruja C et al. Immunophenotype of vitamin D receptor polymorphism associated to risk of HIV-1 infection and rate of disease progression. Curr. HIV Res.8(6) , 487–492 (2010).
  • Haug CJ , MüllerF, RollagH, AukrustP, DegréM, Fr⊘landSS. The effect of 1,25-vitamin D3 on maturation of monocytes from HIV-infected patients varies with degree of immunodeficiency. APMIS104(7–8) , 539–548 (1996).
  • Connor RI , RigbyWF. 1 alpha,25-dihydroxyvitamin D3 inhibits productive infection of human monocytes by HIV-1. Biochem. Biophys. Res. Commun.176(2) , 852–859 (1991).
  • Ross AC , McComseyGA. The role of vitamin D deficiency in the pathogenesis of osteoporosis and in the modulation of the immune system in HIV-infected patients. Clin. Rev. Bone Miner. Metabol.10(4) , 277–278 (2012).
  • Girasole G , WangJM, PedrazzoniMet al. Augmentation of monocyte chemotaxis by 1 alpha,25-dihydroxyvitamin D3. Stimulation of defective migration of AIDS patients. J. Immunol. 145(8) , 2459–2464 (1990).
  • Sudfeld CR , WangM, AboudS, GiovannucciEL, MugusiFM, FawziWW. Vitamin D and HIV progression among Tanzanian adults initiating antiretroviral therapy. PLoS ONE7(6) , e40036 (2012).
  • Kakalia S , SochettEB, StephensD, AssorE, ReadSE, BitnunA. Vitamin D supplementation and CD4 count in children infected with human immunodeficiency virus. J. Pediatr.159(6) , 951–957 (2011).
  • Bang U , KolteL, HitzMet al. Correlation of increases in 1,25-dihydroxyvitamin D during vitamin D therapy with activation of CD4+ T lymphocytes in HIV-1-infected males. HIV Clin. Trials 13(3) , 162–170 (2012).
  • Haug CJ , AukrustP, LienE, MüllerF, EspevikT, Fr⊘landSS. Disseminated Mycobacterium avium complex infection in AIDS: immunopathogenic significance of an activated tumor necrosis factor system and depressed serum levels of 1,25 dihydroxyvitamin D. J. Infect. Dis.173(1) , 259–262 (1996).
  • Eisenhut M . Effect of vitamin D on tuberculosis and HIV replication depends on conversion to calcitriol and concentration. Am. J. Respir. Crit. Care Med.180(8) , 795 (2009).
  • Equils O , HewisonM. A role for vitamin D in placental immunology. J. Infect. Dis.201(12) , 1950–1951 (2010).
  • Yin M , SteinE. The effect of antiretrovirals on vitamin D. Clin. Infect. Dis.52(3) , 406–408 (2011).
  • Bander D , ParczewskiM. Osteoporosis and vitamin D deficiency in HIV-infected patients: genetic and classical factors compared to the HIV-associated ones – review. HIV & AIDS Review11(1) , 1–4 (2012).
  • Madeddu G , SpanuA, SolinasPet al. Bone mass loss and vitamin D metabolism impairment in HIV patients receiving highly active antiretroviral therapy. Q. J. Nucl. Med. Mol. Imaging 48(1) , 39–48 (2004).
  • Masiá M , PadillaS, RobledanoC, LópezN, RamosJM, GutiérrezF. Early changes in parathyroid hormone concentrations in HIV-infected patients initiating antiretroviral therapy with tenofovir. AIDS Res. Hum. Retroviruses28(3) , 242–246 (2012).
  • Ramayo E , González-MorenoMP, MacíasJet al. Relationship between osteopenia, free testosterone, and vitamin D metabolite levels in HIV-infected patients with and without highly active antiretroviral therapy. AIDS Res. Hum. Retroviruses 21(11) , 915–921 (2005).
  • O‘Brien KO , RazaviM, HendersonRA, CaballeroB, EllisKJ. Bone mineral content in girls perinatally infected with HIV. Am. J. Clin. Nutr.73(4) , 821–826 (2001).
  • Childs K , WelzT, SamarawickramaA, PostFA. Effects of vitamin D deficiency and combination antiretroviral therapy on bone in HIV-positive patients. AIDS26(3) , 253–262 (2012).
  • Focà E , MottaD, BorderiMet al. Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz. BMC Infect. Dis. 12 , 38 (2012).
  • Childs KE , FishmanSL, ConstableCet al. Short communication: inadequate vitamin D exacerbates parathyroid hormone elevations in tenofovir users. AIDS Res. Hum. Retroviruses 26(8) , 855–859 (2010).
  • Havens PL , StephensenCB, HazraRet al.; Adolescent Medicine Trials Network (ATN) for HIV/AIDS Interventions 063 study team. Vitamin D3 decreases parathyroid hormone in HIV-infected youth being treated with tenofovir: a randomized, placebo-controlled trial. Clin. Infect. Dis.54(7) , 1013–1025 (2012).
  • Etminani-Esfahani M , KhaliliH, JafariS, AbdollahiA, Dashti-KhavidakiS. Effects of vitamin D supplementation on the bone specific biomarkers in HIV infected individuals under treatment with efavirenz. BMC Res. Notes5(1) , 204 (2012).
  • Arpadi SM , McMahonDJ, AbramsEJet al. Effect of supplementation with cholecalciferol and calcium on 2-y bone mass accrual in HIV-infected children and adolescents: a randomized clinical trial. Am. J. Clin. Nutr. 95(3) , 678–685 (2012).
  • Mondy K , PowderlyWG, ClaxtonSAet al. Alendronate, vitamin D, and calcium for the treatment of osteopenia/osteoporosis associated with HIV infection. J. Acquir. Immune Defic. Syndr. 38(4) , 426–431 (2005).
  • McComsey GA , KendallMA, TebasPet al. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS 21(18) , 2473–2482 (2007).
  • Bolland MJ , GreyAB, HorneAMet al. Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial. J. Clin. Endocrinol. Metab. 92(4) , 1283–1288 (2007).
  • Bolland MJ , GreyAB, HorneAMet al. Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months. J. Bone Miner. Res. 23(8) , 1304–1308 (2008).
  • Huang J , MeixnerL, FernandezS, McCutchanJA. A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis. AIDS23(1) , 51–57 (2009).
  • Lin D , RiederMJ. Interventions for the treatment of decreased bone mineral density associated with HIV infection. Cochrane Database Syst. Rev.2 , CD005645 (2007).
  • Mehta S , MugusiFM, SpiegelmanDet al. Vitamin D status and its association with morbidity including wasting and opportunistic illnesses in HIV-infected women in Tanzania. AIDS Patient Care STDS 25(10) , 579–585 (2011).
  • Lochner JD , SchneiderDJ. The relationship between tuberculosis, vitamin D, potassium and AIDS. A message for South Africa? S. Afr. Med. J.84(2) , 79–82 (1994).
  • Wejse C , GomesVF, RabnaPet al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am. J. Respir. Crit. Care Med. 179(9) , 843–850 (2009).
  • Realegeno S , ModlinRL. Shedding light on the vitamin D–tuberculosis–HIV connection. Proc. Natl Acad. Sci. USA108(47) , 18861–18862 (2011).
  • Haug CJ , MüllerF, AukrustP, Fr⊘landSS. Different effect of 1,25-dihydroxyvitamin D3 on replication of Mycobacterium avium in monocyte-derived macrophages from human immunodeficiency virus-infected subjects and healthy controls. Immunol. Lett.63(2) , 107–112 (1998).
  • Campbell GR , SpectorSA. Vitamin D inhibits human immunodeficiency virus type 1 and Mycobacterium tuberculosis infection in macrophages through the induction of autophagy. PLoS Pathog.8(5) , e1002689 (2012).
  • Sroussi HY , Burke-MillerJ, FrenchALet al. Association among vitamin D, oral candidiasis, and calprotectinemia in HIV. J. Dent. Res. 91(7) , 666–670 (2012).
  • Huang JC , KuoMC, HwangSJ, HwangDY, ChenHC. Vitamin D-mediated hypercalcemia as the initial manifestation of pulmonary cryptococcosis in an HIV-uninfected patient. Intern. Med.51(13) , 1793–1796 (2012).
  • Mda S , van Raaij JM, de Villiers FP, MacIntyre UE, Kok FJ. Short-term micronutrient supplementation reduces the duration of pneumonia and diarrheal episodes in HIV-infected children. J. Nutr.140(5) , 969–974 (2010).
  • French AL , AdeyemiOM, AgnielDMet al. The association of HIV status with bacterial vaginosis and vitamin D in the United States. J. Womens Health (Larchmt) 20(10) , 1497–1503 (2011).
  • Mascitelli L , PezzettaF, GoldsteinMR. Cholesterol, vitamin D and cardiovascular prevention in HIV patients treated with antiretroviral therapy. Int. J. Cardiol.146(3) , 441–442 (2011).
  • Choi AI , LoJC, MulliganKet al. Association of vitamin D insufficiency with carotid intima-media thickness in HIV-infected persons. Clin. Infect. Dis. 52(7) , 941–944 (2011).
  • Ross AC , JuddS, KumariMet al. Vitamin D is linked to carotid intima-media thickness and immune reconstitution in HIV-positive individuals. Antivir. Ther. 16(4) , 555–563 (2011).
  • Shikuma CM , SetoT, LiangCYet al. Vitamin D levels and markers of arterial dysfunction in HIV. AIDS Res. Hum. Retroviruses 28(8) , 793–797 (2012).
  • Lai H , DetrickB, FishmanEKet al. Vitamin D deficiency is associated with the development of subclinical coronary artery disease in African Americans with HIV infection: a preliminary study. J. Investig. Med. 60(5) , 801–807 (2012).
  • Lai H , GerstenblithG, FishmanEKet al. Vitamin D deficiency is associated with silent coronary artery disease in cardiovascularly asymptomatic African Americans with HIV infection. Clin. Infect. Dis. 54(12) , 1747–1755 (2012).
  • Longenecker CT , HilemanCO, CarmanTLet al. Vitamin D supplementation and endothelial function in vitamin D deficient HIV-infected patients: a randomized placebo-controlled trial. Antivir. Ther. 17(4) , 613–621 (2012).
  • Szep Z , GuaraldiG, ShahSSet al. Vitamin D deficiency is associated with Type 2 diabetes mellitus in HIV infection. AIDS 25(4) , 525–529 (2011); erratum: 25(13) , 1682 (2011).
  • van den Bout-van den Beukel CJ , van den Bos M, Oyen WJ et al. The effect of cholecalciferol supplementation on vitamin D levels and insulin sensitivity is dose related in vitamin D-deficient HIV-1-infected patients. HIV Med.9(9) , 771–779 (2008).
  • Gharakhanian S , KotlerDP. Diabetes mellitus, HIV infection, and vitamin D: time to act or time to think? AIDS25(4) , 531–533 (2011).
  • Hammond E , McKinnonE, GlendenningP, WilliamsR, MallalS, PhillipsE. Association between 25-OH vitamin D and insulin is independent of lipoatrophy in HIV. Clin. Endocrinol.76(2) , 201–206 (2012).
  • Merhi ZO , SeiferDB, WeedonJet al. Circulating vitamin D correlates with serum antiMüllerian hormone levels in late-reproductive-aged women: Women‘s Interagency HIV Study. Fertil. Steril. 98(1) , 228–234 (2012).
  • Milazzo L , MazzaliC, BestettiGet al. Liver-related factors associated with low vitamin D levels in HIV and HIV/HCV coinfected patients and comparison to general population. Curr. HIV Res. 9(3) , 186–193 (2011).
  • Estrella MM , KirkGD, MehtaSHet al. Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users. AIDS 26(3) , 295–302 (2012).
  • Adams JS , FernandezM, GacadMAet al. Vitamin D metabolite-mediated hypercalcemia and hypercalciuria patients with AIDS- and non-AIDS-associated lymphoma. Blood 73(1) , 235–239 (1989).
  • Lavae-Mokhtari M , Mohammad-KhaniS, SchmidtRE, StollM. [Acute renal failure and hypercalcemia in an AIDS patient on tenofovir and low-dose vitamin D therapy with immune reconstitution inflammatory syndrome]. Med. Klin.104(10) , 810–813 (2009).
  • Gray JD , BottomleyW, LaytonAM, CotterillJA, MonteiroE. The use of calcipotriol in HIV-related psoriasis. Clin. Exp. Dermatol.17(5) , 342–343 (1992).
  • Hardman KA , HeathDA, NelsonHM. Hypercalcaemia associated with calcipotriol (Dovonex) treatment. BMJ306(6882) , 896 (1993).
  • Finkelstein JL , MehtaS, DugganCPet al. Predictors of anaemia and iron deficiency in HIV-infected pregnant women in Tanzania: a potential role for vitamin D and parasitic infections. Public Health Nutr. 15(5) , 928–937 (2012).
  • Finkelstein JL , MehtaS, DugganCet al. Maternal vitamin D status and child morbidity, anemia, and growth in human immunodeficiency virus-exposed children in Tanzania. Pediatr. Infect. Dis. J. 31(2) , 171–175 (2012).
  • Mehta S , SpiegelmanD, AboudSet al. Lipid-soluble vitamins A, D, and E in HIV-infected pregnant women in Tanzania. Eur. J. Clin. Nutr. 64(8) , 808–817 (2010).
  • Siegfried N , IrlamJH, VisserME, RollinsNN. Micronutrient supplementation in pregnant women with HIV infection. Cochrane. Database. Syst. Rev.3 , CD009755 (2012).
  • Rutstein R , DownesA, ZemelB, SchallJ, StallingsV. Vitamin D status in children and young adults with perinatally acquired HIV infection. Clin. Nutr.30(5) , 624–628 (2011).
  • Pasquet A , VigetN, AjanaFet al. Vitamin D deficiency in HIV-infected patients: associated with non-nucleoside reverse transcriptase inhibitor or efavirenz use? AIDS 25(6) , 873–874 (2011).
  • Welz T , ChildsK, PostFA. Do nevirapine and efavirenz affect vitamin D homeostasis similarly? AIDS25(6) , 875–876 (2011).
  • Cozzolino M , VidalM, ArcidiaconoMV, TebasP, YarasheskiKE, DussoAS. HIV-protease inhibitors impair vitamin D bioactivation to 1,25-dihydroxyvitamin D. AIDS17(4) , 513–520 (2003).
  • Fox J , PetersB, PrakashM, ArribasJ, HillA, MoecklinghoffC. Improvement in vitamin D deficiency following antiretroviral regime change: results from the MONET trial. AIDS Res. Hum. Retroviruses27(1) , 29–34 (2011).
  • Arpadi SM , McMahonD, AbramsEJet al. Effect of bimonthly supplementation with oral cholecalciferol on serum 25-hydroxyvitamin D concentrations in HIV-infected children and adolescents. Pediatrics 123(1) , e121–e126 (2009).
  • Irlam JH , VisserME, RollinsN, SiegfriedN. Micronutrient supplementation in children and adults with HIV infection. Cochrane Database Syst. Rev.4 , CD003650 (2005); update: 12 , CD003650 (2010).
  • Ndeezi G , TylleskärT, NdugwaCM, TumwineJK. Effect of multiple micronutrient supplementation on survival of HIV-infected children in Uganda: a randomized, controlled trial. J. Int. AIDS Soc.13 , 18 (2010).
  • Spindel SJ , HamillRJ, GeorghiouPR, LackeCE, GreenLK, MalletteLE. Case report: vitamin D-mediated hypercalcemia in fungal infections. Am. J. Med. Sci.310(2) , 71–76 (1995).
  • Ali MY , GopalKV, LlerenaLA, TaylorHC. Hypercalcemia associated with infection by Cryptococcus neoformans and Coccidioides immitis. Am. J. Med. Sci.318(6) , 419–423 (1999).
  • Tuon FF , NiheiCH, GryschekRC, SeguroAC. Vitamin D intoxication: a cause of hypocalcaemia and acute renal failure in a HIV patient. Int. J. STD AIDS19(2) , 137–138 (2008).
  • Villamor E . A potential role for vitamin D on HIV infection? Nutr. Rev.64(5 Pt 1) , 226–233 (2006).
  • Spector SA . Vitamin D and HIV: letting the sun shine in. Top. Antivir. Med.19(1) , 6–10 (2011).
  • Lake JE , AdamsJS. Vitamin D in HIV-infected patients. Curr. HIV/AIDS Rep.8(3) , 133–141 (2011).
  • Overton ET , YinMT. The rapidly evolving research on vitamin D among HIV-infected populations. Curr. Infect. Dis. Rep.13(1) , 83–93 (2011).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.